The Eli Lilly and Company Foundation has committed US $30 million in funding to further support The Lilly MDR-TB Partnership in its fight against multidrug- resistant tuberculosis – a disease that disproportionately affects developing countries and kills more than 150,000 people each year. The announcement was made ahead of the opening of the 42nd Union World Conference on Lung Health in Lille, France, later this week.

><table width='100%' border=0 cellspacing=0><tr><td style='FONT-FAMILY: Arial; FONT-SIZE: 18px; FONT-WEIGHT: bold; COLOR: #0253B7;'>Lilly Foundation Commits US $30 Million to The Lilly MDR-TB Partnership</td></tr><tr><tr><td style='FONT-FAMILY: Arial; FONT-SIZE: 11px; '>Funding Continues Partnership

Lilly Foundation Commits US $30 Million to The Lilly MDR-TB Partnership

Funding Continues Partnerships Fight against Multidrug-Resistant Tuberculosis

More From This Section

Tata Vista nominated for European Car of the Year award

Barclays Wealth crowned best private bank in India

Cisco Advantage Now! Road Show to Help Partners Build a Stronger Small Business Practice

Janesh Moorjani to lead Enterprise and Public Sector Business for Cisco India & SAARC

Explore News